We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Amin Nassar MD

Amin Nassar MD

Hematology/Oncology Fellow, Yale University, New Haven, Connecticut

Amin Nassar, MD, is a hematology/oncology fellow at Yale University. He received his medical degree from the American University of Beirut and completed residency at Brigham and Women's Hospital. Dr. Nassar also pursued a two-year postdoctoral training at Brigham and Women's Hospital where he worked under the mentorship of Professors Dr. David Kwiatkowski, Dr. Toni Choueiri, and Dr. Matthew Freedman at Harvard Medical School. His research focuses on the identification of genomic biomarkers across ancestral populations with cancer. Dr. Nassar currently serves on the editorial board of "Molecular biology reports," "Translational oncology," and "Frontiers in Oncology." He is also one of the Associate Guest editors for the journal "Frontiers in Oncology" and is part of the editorial team for the Elsevier's PracticeUpdate Bladder Cancer Center of Excellence. Dr. Nassar is interested in a career as a physician–scientist with a clinical focus in thoracic oncology.